课题基金 / 基金详情

Building a Novel Antibiotic Stewardship intervention for nursing homes

Building a Novel Antibiotic Stewardship intervention for nursing homes
为疗养院建立新型抗生素管理干预措施
批准号:
8900251
负责人:
Christopher J Crnich
金额:
$48.97万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2017-07-31

项目摘要

项目成果

Christopher J Crnich的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):疗养院高达75%的抗生素使用是不适当的。不适当的抗生素使用增加了疗养院居民发生不良药物事件、艰难梭菌感染和感染耐药细菌的风险,这些疾病可能会传播给其他人。养老院抗生素管理干预的结果好坏参半。虽然针对提供者知识和影响处方决策的工作系统方面的多组分干预措施似乎可以减少养老院中不适当的抗生素使用,但这些干预措施的作用机制尚不清楚。在缺乏这些知识的情况下,这些干预措施将不可能成功地传播到其他养老院环境。因此,迫切需要进行疗养院抗生素管理研究,不仅要评估干预措施对处方模式的影响,还要评估干预措施调节变化的机制。我们的长期目标是减少养老院中不适当的抗生素使用。因此,我们小组开发了一种新的抗生素管理干预措施,目标是提供者的知识以及影响养老院抗生素决策的重要工作系统因素。这个特别的应用程序的目的是展示我们在两个州的疗养院进行的抗菌管理干预的有效性,并开发一种资源,以促进传播到其他疗养院设置。我们将通过三个具体目标实现该项目的目标:1)为最佳实施量身定做抗生素管理干预措施;2)评估其对研究疗养院抗生素使用的影响;以及3)利用所获得的知识开发传播工具包。在第一个目标中,我们将使用人的因素分析来确定实施抗生素管理干预的障碍和促进者。干预措施的组成部分将被量身定做,以克服这些障碍,并将制定一项实施方案,其中包括研究疗养院关键信息者的结构化输入。在第二个目标中,将使用威斯康星大学首创的质量改进协作方法在研究性疗养院实施量身定制的抗生素管理干预,并将抗生素使用措施与控制设施进行比较。在第三个目标中,对干预措施的保真度、可持续性和机制进行混合方法评估所产生的知识将与干预调解研究成果结合起来,用于开发一个传播工具包。我们将用来定制我们的干预措施并支持其实施的方法(协作质量改进),以及我们将用来开发传播工具包的严格的计划评估,这些都是该提案的创新方面。这项拟议的研究意义重大;因为预计它将导致 一种可广泛推广的多方面干预措施,可有效减少抗生素在设施中的使用,这反过来又将减少艰难梭菌感染以及疗养院及其服务社区中抗生素耐药性的出现和传播。
英文摘要
DESCRIPTION (provided by applicant): Up to 75% of antibiotic use in nursing homes is inappropriate. Inappropriate antibiotic use increases the nursing home resident's risk of adverse drug events, Clostridium difficile infection and infection with antibiotic- resistant bacteria, whih may then be spread to others. Results of antibiotic stewardship interventions in nursing homes have been mixed. While multi-component interventions targeting provider knowledge and aspects of the work system influencing prescribing decisions appear to reduce inappropriate antibiotic use in nursing homes, the mechanisms by which these interventions work is unclear. In the absence of this knowledge, successful dissemination of these interventions to other nursing home settings will not be possible. Consequently, there is a critical need for nursing home antibiotic stewardship studies that not only evaluate the impact of interventions on prescribing patterns but also evaluate the mechanisms by which they mediate change. Our long-term goal is to reduce inappropriate antibiotic use in nursing homes. Accordingly, our group has developed a novel antibiotic stewardship intervention that targets provider knowledge as well as important work system factors influencing antibiotic decision-making in nursing homes. The objectives of this particular application are to demonstrate the effectiveness of our antibioti stewardship intervention in nursing homes in two states and develop a resource to facilitate dissemination to other nursing home settings. We will achieve the objectives of this project through three specific aims: 1) tailor the antibiotic stewardship intervention for optimal implementation; 2) assess its impact on antibiotic use in study nursing homes; and 3) use knowledge gained to develop a dissemination toolkit. In the first aim, we will use human factors analyses to identify barriers and facilitators to implementation of the antibiotic stewardship intervention. Components of the intervention will be tailored to overcome these barriers and an implementation package will be developed with structured input from key informants in study nursing homes. In the second aim, the tailored antibiotic stewardship intervention will be implemented in study nursing homes using a quality improvement collaborative approach pioneered at the University of Wisconsin and antibiotic utilization measures will be compared with control facilities. In the third aim, knowledge generated from a mixed-methods assessment of intervention fidelity, sustainability and mechanisms by with the intervention mediates study outcomes will be used to develop a dissemination toolkit. The methods we will used to tailor our intervention and support its implementation (quality improvement collaborative) as well as the rigorous program evaluation we will employ to develop a dissemination toolkit are all innovative aspects of this proposal. The proposed research is significant; because it is expected to result in a multi-faceted intervention that can be exported broadly to effectively reduce improve antibiotic use in facilities, which will, in turn, will reduce C. difficile infections and the emergence and spread of antibiotic resistance in nursing homes and the communities they serve.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a novel antibiogram tool to improve empiric antibiotic prescribing in nursing homes
  • 批准号:
    10099724
  • 项目类别:
  • 资助金额:
    $49.95万
  • 财政年份:
    2020
  • 负责人:
    Christopher J Crnich
  • 依托单位:
Developing a novel antibiogram tool to improve empiric antibiotic prescribing in nursing homes
  • 批准号:
    10268207
  • 项目类别:
  • 资助金额:
    $49.31万
  • 财政年份:
    2020
  • 负责人:
    Christopher J Crnich
  • 依托单位:
Building a Novel Antibiotic Stewardship intervention for nursing homes
  • 批准号:
    8744483
  • 项目类别:
  • 资助金额:
    $49.84万
  • 财政年份:
    2014
  • 负责人:
    Christopher J Crnich
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
miR-2796和novel_13靶向磷脂酶C基因调控Q烟粉虱高温耐受性的分子机制
  • 批准号:
    32402377
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2024
  • 负责人:
    戴恬美
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位: